PTBP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.281400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.670000E-01
Normal-vs-Stage2
5.511200E-01
Normal-vs-Stage3
2.566600E-01
Normal-vs-Stage4
2.108400E-01
Stage1-vs-Stage2
4.821000E-01
Stage1-vs-Stage3
4.055800E-01
Stage1-vs-Stage4
8.067800E-01
Stage2-vs-Stage3
6.339800E-02
Stage2-vs-Stage4
7.139400E-01
Stage3-vs-Stage4
4.229600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.946400E-01
Normal-vs-AfricanAmerican
4.757800E-01
Normal-vs-Asian
6.982400E-01
Caucasian-vs-AfricanAmerican
9.039000E-01
Caucasian-vs-Asian
5.891700E-02
AfricanAmerican-vs-Asian
1.644440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.255400E-01
Normal-vs-Female
5.326000E-01
Male-vs-Female
7.648400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.398170E-01
Normal-vs-Age(41-60Yrs)
5.635600E-01
Normal-vs-Age(61-80Yrs)
4.807000E-01
Normal-vs-Age(81-100Yrs)
9.724000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.670560E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.191000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.220200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.067160E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.725800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.953600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.512800E-01
Normal-vs-Daily Drinker
3.941600E-01
Normal-vs-Weekly Drinker
7.871400E-01
Normal-vs-Occasional Drinker
9.476200E-01
Normal-vs-Social Drinker
3.515000E-01
Non Drinker-vs-Daily Drinker
7.218000E-01
Non Drinker-vs-Weekly Drinker
4.782800E-01
Non Drinker-vs-Occasional Drinker
2.876200E-01
Non Drinker-vs-Social Drinker
8.205600E-01
Daily Drinker-vs-Weekly Drinker
2.839400E-01
Daily Drinker-vs-Occasional Drinker
1.614220E-01
Daily Drinker-vs-Social Drinker
9.145000E-01
Weekly Drinker-vs-Occasional Drinker
7.612800E-01
Weekly Drinker-vs-Social Drinker
3.219400E-01
Occasional Drinker-vs-Social Drinker
2.100600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.841800E-01
Normal-vs-Grade 2
8.584800E-01
Normal-vs-Grade 3
8.249400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.833400E-01
Grade 1-vs-Grade 3
3.686000E-01
Grade 1-vs-Grade 4
8.841800E-01
Grade 2-vs-Grade 3
3.384600E-01
Grade 2-vs-Grade 4
8.584800E-01
Grade 3-vs-Grade 4
8.249400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.984600E-01
Normal-vs-NonDiabetic
6.157400E-01
Diabetic-vs-NonDiabetic
2.231000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.746600E-01
Normal-vs-NoPancreatitis
5.222800E-01
Pancreatitis-vs-NoPancreatitis
8.334000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.954200E-01
Normal-vs-N1
5.250800E-01
N0-vs-N1
5.954400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.686600E-01
Normal-vs-TP53-NonMutant
4.348600E-01
TP53-Mutant-vs-TP53-NonMutant
4.423500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
